Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms PHOTAC-I-1 |
Target |
Action degraders |
Mechanism BRD2 degraders(Bromodomain-containing protein 2 degraders), BRD3 degraders(Bromodomain-containing protein 3 degraders), BRD4 degraders(Bromodomain-containing protein 4 degraders) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC44H43ClN10O8S |
InChIKeyLQCVQUVQOKDZMA-XVPPCTQSSA-N |
CAS Registry- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | United States | 21 Feb 2020 | |
Neoplasms | Preclinical | Germany | 21 Feb 2020 |